|
1064
|
Vaxelis
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1065
|
Infanrix
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1066
|
Infanrix-IPV+Hib
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Conjugate
|
GlaxoSmithKline Biologicals S.A
|
Approved
|
Intramuscular
|
NA
|
NCT01309646
|
|
1067
|
Infanrix/Hib
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline
|
Approved
|
Intramuscular
|
NA
|
NCT00696423
|
|
1068
|
Infanrix-IPV
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1069
|
Boostrix
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1070
|
Pentacel
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
Sanofi Pasteur Limited and Sanofi Pasteur SA
|
Approved
|
Intramuscular
|
NA
|
NCT00804284
|
|
1071
|
Daptacel
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NCT00258895
|
|
1072
|
Quadracel
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1073
|
Adacel
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1074
|
Pediarix
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1075
|
Kinrix
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
18980534
|
NA
|
|
1076
|
Tenivac
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1077
|
Decavac
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1078
|
Tdvax
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Toxoid
|
MassBiologics
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1079
|
DT Generic
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1080
|
DT Polio Adsorbed
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
21441781
|
NA
|
|
1081
|
Pentaxim
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
21749196
|
NA
|
|
1082
|
Infanrix hexa
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Conjugate
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NCT01353703
|
|
1083
|
Hexaxim
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur
|
Approved
|
Intramuscular
|
NA
|
NCT02428491
|
|
1084
|
Shan-5
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Healthcare India Private Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1085
|
Actacel
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Subunit
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1086
|
Quinvaxem inj.
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Subunit
|
Berna Biotech Korea Corp.
|
Approved
|
Intramuscular
|
22889824
|
NA
|
|
1087
|
EasyFive-TT
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Panacea Biotech Ltd.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1088
|
Pediacel
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
21999652
|
NA
|
|
1089
|
Tripacel
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1090
|
Tetravac or Tetravac Acellulaire
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1091
|
Boostrix Polio
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1092
|
Td-pur
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Novartis vaccine Diagnostics GmbH & Co. KG.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1093
|
REPEVAX
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1094
|
Adacel Polio
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1095
|
Tripedia
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Toxoid
|
Sanofi Pasteur, Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1096
|
Td Polio Adsorbed
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1097
|
Td Adsorbed
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Toxoid
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1098
|
Tetanus Toxoid Adsorbed
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Toxoid
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1099
|
Diphtheria and Tetanus Toxoids Adsorbed
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Toxoid
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1294
|
diTekiBooster
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Swedish Institute for Infectious Disease Control
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT00870350
|
|
1295
|
COVAXIS
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Swedish Institute for Infectious Disease Control
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT00870350
|
|
1296
|
Squarekids
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Kitasato Daiichi Sankyo Vaccine Co., Ltd.
|
Clinical - Discontinued
|
Subcutaneous
|
NA
|
NCT02907216
|
|
1297
|
TETRAXIM
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT01437423
|
|
1298
|
Tetrabik
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Merck Sharp & Dohme Corp.
|
Clinical - Phase 4
|
Subcutaneous
|
NA
|
NCT01926015
|
|
1299
|
Eupenta Inj.
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Conjugate
|
LG Chem
|
Clinical - Phase 4
|
NA
|
NA
|
NCT04056728
|
|
1300
|
REVAXIS
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
NA
|
NA
|
NCT00447525
|
|
1301
|
HEXAVAC
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT01457547
|
|
1302
|
Td-Rix
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT01262924
|
|
1303
|
Tetanus Monovalent vaccine
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Toxoid
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
NA
|
NA
|
NCT00928785
|
|
1304
|
SP306 (in Japan)
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT02089347
|
|
1305
|
BK1301
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Mitsubishi Tanabe Pharma Corporation
|
Clinical - Phase 3
|
Subcutaneous
|
NA
|
NCT02118961
|
|
1306
|
Tritanrix-HepB/Hib-MenAC
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00136604
|
|
1307
|
Tritanrix-HepB/Hib
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00313911
|
|
1308
|
BR-TD-1001
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Toxoid
|
Boryung Biopharma Co., Ltd.
|
Clinical - Phase 3
|
Intramuscular
|
26091286
|
NCT04618939
|
|
1309
|
SP0204
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Subcutaneous
|
NA
|
NCT02274285
|
|
1310
|
DD 687 or DF 098
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Subcutaneous
|
NA
|
NCT02274285
|
|
1311
|
DTaP-IPVvero
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Statens Serum Institut
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00655148
|
|
1312
|
DTaP-IPVmkc
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Statens Serum Institut
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00655148
|
|
1313
|
Tritanrix-HepB/ Hiberix
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00473668
|
|
1314
|
GSK323527A
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00332566
|
|
1315
|
V441
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Conjugate
|
Merck Sharp & Dohme Corp.
|
Clinical - Phase 3
|
NA
|
NA
|
NCT00092469
|
|
1316
|
BK1310
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Mitsubishi Tanabe Pharma Corporation
|
Clinical - Phase 3
|
Subcutaneous
|
NA
|
NCT03891758
|
|
1317
|
SHAN6
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT04429295
|